| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8448325 | European Journal of Cancer | 2009 | 9 Pages |
Abstract
In a cohort of colorectal cancer patients, those with MMR-deficient tumours seem not to benefit from 5-FU-based chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rodrigo Jover, Pedro Zapater, Antoni Castells, Xavier Llor, Montserrat Andreu, JoaquÃn Cubiella, Francesc Balaguer, Laura Sempere, Rosa M. Xicola, Luis Bujanda, Josep M. Reñé, Juan Clofent, Xavier Bessa, Juan D. Morillas, David Nicolás-Pérez,